Important News From ASIPP - National IPM-Qualified Clinical Data Registry

  

ASIPP recently brought you exciting news for interventional pain management in announcing the National IPM-Qualified Clinical Data Registry (QCDR) in collaboration with ArborMetrix. Nearly 200 ASIPP members have already expressed interest in joining the QCDR, and registration is underway. If you have already signed up, please pass along this information to anyone else who could benefit from this opportunity.   

 

Participating in the QCDR is a valuable opportunity not only to meet reporting requirements, but also to provide outcome data and compare yourself with others in ASIPP and nationwide. We encourage you to sign up for the QCDR before the end of the year, while ASIPP completes the approval process with CMS.

 

To sign up for the National IPM QCDR, you can respond to this email or send an email to [email protected]. We will then send you registration forms to complete. There is no commitment or cost to you until we are approved for the QCDR for 2017 reporting. 

 

As you are well aware, CMS has issued the final rule on its value-based care entitled, "Merit-Based Incentive Payment System Combining Quality Measures, Meaningful Use or Advancing Care Information, Clinical Improvement Activities and Costs." Because of our efforts, CMS has made substantial changes to enable us to avoid penalties. The QCDR reporting mechanism and specifically the NIPM-QCDR will complete the collection and submission of MIPS requirements.

 

This unique registry developed only for interventional pain physicians by ASIPP will:

 

 

Now the pathway is clear. We can not only avoid the penalties, but also be exceptional performers and earn high level bonuses. We will also have the data to present in the future.

 

If you have any further questions, we can arrange for you to talk to one of the representatives from ArborMetrix with whose collaboration we are preparing the registry, or you can also attend one of the webinars we will be starting soon.

 

Click HERE for more information and to register.

  

On the November 2016 edition of the ASIPP Podcast we'll list the didactic courses ASIPP has scheduled for next year; we'll meet ASIPP's new director of operations; in the news segment we'll find out if pain is contagious, the latest medical marijuana news, some pediatric pain news, and much more; and we'll wrap things up with a study about whether rats are ticklish.

  

Click HERE

Significant Change to DEA Registration Renewal Process

  

Through a notice on its website, the Drug Enforcement Administration (DEA) recently announced significant changes to its registration renewal process.  Effective January 1, 2017, the DEA is eliminating the informal grace period which the agency has previously allowed for registrants to renew their registrations.  Only one renewal notice will be sent to each registrant's "mail to" address approximately 65 days prior to the expiration date; no other reminders to renew the DEA registration will be provided.  The notice also advises that online capability to renew a DEA registration after the expiration date will no longer be available, and that failure to file a renewal application by midnight EST of the expiration date will result in the "retirement" of the registrant's DEA number.  The original DEA registration will not be reinstated.  In addition, paper renewal applications will not be accepted the day after the expiration date.  If DEA has not received the paper renewal application by the day of the expiration date, mailed in renewal applications will be returned and the registrant will have to apply for a new DEA registration.

  

DEA

   

Start Planning NOW!
ASIPP® Abstracts Submission for 2017 Annual Meeting OPEN

  

Registration will be open for Abstract Submissions is now available.

  

The American Society of Interventional Pain Physicians will hold its 19th Annual Meeting April 20-22 in Las Vegas at Caesar's Palace.

  

This year, we will be making significant changes to the Abstract and Poster Sessions. Submissions will be in two categories: Resident/Fellow and Physician.  Selected posters will be on display forall meeting participants during all breaks and meal times.

  

The Abstract Committee will select the top 25 for publication in Pain Physician and of those 10 will be selected for Abstract presentation and judging during the Annual Meeting. The top 3 will receive cash prizes.

Submit and review this year's rules.

  

Analgesics and opioids were linked to a higher risk of developing medication-overuse headache compared with other treatments in patients receiving acute migraine treatment, researchers reported.

Based on a systematic literature review, the pooled relative risk was 0.65 (relative risk reduction of 35%) for triptans versus analgesics. For ergots versus analgesics, a similar trend was observed in favor of ergots with a relative risk of 0.41, according to Kristian Thorlund, PhD, of McMaster University in Ontario, Canada, and colleagues.

  

  

Chronic pain is often associated with a range of comorbidities that are either not recognized or treated separately from the pain. Failure to adequately treat pain comorbidities results in a soaring of pain scores, adding to the challenge of managing chronic pain.

 

The biopsychosocial model of pain management allowing for the comprehensive treatment pain and its comorbidities-many often in the psychological realm-is now recognized as a most effective way of managing chronic pain.

  

  

Clinical Pain Advisor

  

Among patients with fibromyalgia, motivational interviewing (MI) to promote physical exercise improved physical function and fibromyalgia (FM) symptoms in opioid nonusers but not in opioid users, according to a study published in The Journal of Rheumatology.

"Exercise is an important component in the management of FM. Given that FM is a chronic condition, exercise has to be sustained long term," Dennis C. Ang, MD, MS, of Wake Forest School of Medicine, told Clinical Pain Advisor. 

  

  

Clinical Pain Advisor

  

Spondyloarthritis   (SpA) is an umbrella term used to describe a group of chronic inflammatory diseases involving the joints and entheses. Ankylosing spondylitis (AS) is the most common form, affecting 0.2% to 0.5% of the US population.[1] In patients with AS, the spine and vertebrae are typically affected, which can result in back pain, impaired mobility, and reduced work productivity and quality of life (QoL).
 

Patients with AS and other forms of SpA, such as psoriatic arthritis (PsA), have been found to have a high prevalence of psychological comorbidities, including depression, anxiety, and sleep disturbances, which can further reduce their QoL and adversely affect their outcomes. Therefore, to optimize the care and outcomes of patients with SpA, clinicians must strive to effectively treat the condition and its symptoms while also addressing potential psychological risk factors and comorbidities. 

  

  

Rheumatology Advisor

  

ROCKVILLE , Md. , Dec. 13, 2016 /PRNewswire/ -- As part of National Spine & Pain Centers' effort to provide quality care and pain management solutions to patients on a wider scale, the recent acquisition of highly esteemed Premier Pain and Specialty Anesthesia Associates in New Jersey is a significant milestone. Patients suffering from acute or chronic pain conditions will greatly benefit, as nationally recognized pain specialists join forces with one of America's leading practices in National Spine & Pain Centers (NSPC).

Chief Medical Officer of NSPC, Dr. Les Zuckerman, states, "Premier is New Jersey's best and largest interventional pain group. We've known and worked with their founders for many years, so we feel confident that they will easily dovetail into the NSPC family. Not only does Premier solidify our presence in the North East US, but their addition will open up tremendous opportunities in research & development and help attract top fellowship-trained physicians. Dr. Peter Staats, one of their leaders, is formerly past president of our largest national society (ASIPP). With his help, we foresee continued efforts to strengthen our medical field on a national scale and to continue our efforts to bring together the best doctors in the country."

PR News Wire

in   San Diego, CA | February 23-26, 2017 at the Manchester Grand Hyatt.

  

Click Here for more information.

Brochure